1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Eversource Energy said it completed the sale of Aquarion Water Company to Aquarion Water Authority, a Connecticut public entity, for $2.4 billion in cash. The company expects an after-tax non-cash charge of about $115 million, or $0.31 per share, in the second quarter of 2026, and it revised its 2026 non-GAAP EPS guidance to $4.57 to $4.72 per share, which excludes Aquarion earnings going forward.
Total purchase price was $2.4 billion in cash; adjusted net equity proceeds of about $1.7 billion will be used to pay down Eversource debt.
After-tax non-cash charge of about $115 million, or $0.31 per share, expected in Q2 2026.
Revised 2026 non-GAAP guidance is $4.57 to $4.72 per share; the prior base-year midpoint cited is $4.65 per share.
Sale was approved by the Connecticut Public Utilities Regulatory Authority on March 25, 2026, after a definitive agreement signed January 27, 2025.
Talos Energy and an affiliate of Ridgewood Energy agreed on June 30, 2026 to buy oil and gas properties in the Gulf of America from Shell Offshore for an unadjusted $1.7 billion, with Talos's share at $850 million. Talos expects its final net cash consideration to be about $450 million to $500 million, and it plans to fund the deal with cash on hand and debt, which shareholders should weigh against the added production and reserves and the closing uncertainty.
Talos's share of the unadjusted purchase price is $850 million, with a $42.5 million deposit already in escrow and credited at closing.
Acquired assets include about 23 MMBoe of proved reserves, 10 MMBoe of probable reserves, and first quarter 2026 average production of about 16 MBoe/d (about 77% oil).
BP has a 30-day preferential right on the Na Kika interests; if exercised, Talos would acquire only the Coulomb field interest.
The credit agreement amendment raises the borrowing base from $700 million to $850 million ($800 million if BP exercises its right), effective upon closing, and the deal is expected to close by the end of 2026.
Oramed and Scilex Holding agreed on June 25, 2026 to a further extension of Scilex's payment obligations to Oramed under two senior notes. Scilex has paid $0.5 million so far, with $5 million due by July 31, 2026 and the remaining balance due by September 30, 2026. The filing also says Oramed's board approved amended bylaws effective June 25, 2026 that change stockholder written consent procedures.
Scilex owed approximately $29.5 million under the Tranche A Note and $6.7 million under the Tranche B Note as of June 30, 2026.
Oramed received $0.5 million from Scilex on June 25, 2026; $5 million is due on or before July 31, 2026, and the remaining balance on or before September 30, 2026.
If Scilex does not pay in full by September 30, 2026, the first $1.5 million received would be treated as a non-refundable extension fee, and Scilex has agreed to settle the remaining amount with Scilex common stock.
Fifth Amended and Restated Bylaws, effective June 25, 2026, revise record date procedures for written consent, eliminate a information requirement for record date requests, and set a 60-day delivery window for consents.
NIKE reported fiscal fourth-quarter 2026 revenue of $11.0 billion, down 1% on a reported basis, and diluted EPS of $0.72, up from $0.14 a year earlier. The EPS figure includes a $0.52 benefit from the expected recovery of IEEPA tariffs, and the filing gives no guidance for future periods. For full fiscal 2026, revenue was flat at $46.4 billion and diluted EPS fell 3% to $2.10.
Q4 revenue $11.0 billion, down 1% reported and down 4% currency-neutral; NIKE Direct down 7%
Q4 diluted EPS $0.72 vs. $0.14 a year earlier, including a $0.52 benefit from expected IEEPA tariff recovery
Fiscal 2026 revenue $46.4 billion, flat; net income $3.1 billion, down 3%; diluted EPS $2.10, down 3%
Fiscal 2026 dividends of $2.4 billion, up 5%; share repurchases of $123 million
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.